It has been shown that shear regulators can selectively induce BCL2A1-dependent tumor cells, leading to apoptosis of NSCLC cells [39], while targeting the intrinsic pathway of BCL-2-related apoptosis can effectively treat lung adenocarcinoma [40]. This evidence concerns the gene BCL2A1 and non-small cell lung carcinoma.